El tabaco y la poliédrica nicotina

Referencias bibliográficas

• Ashare, R.L., Falcone, M., Lerman, C. (2013). Cognitive function during nicotine withdrawal: implications for nicotine dependence treatment. Neuropharmacology, (en prensa) doi:pii: S0028-3908(13)00180-9. 10.1016/j.neuropharm.2013.04.034
• Bandiera, F.C., Richardson, A.K., Lee, D.J., He, J.P., Merikangas, K.R. (2011). Secondhand smoke exposure and mental health among children and adolescents. Archives of Pediatrics & Adolescent Medicine, 165, 332-338.
• Becker, J.B., Hu, M. (2008). Sex diff erences in drug abuse. Frontiers in Neuroendocrinology, 29, 36-47.
• Bierut, L.J. (2009). Nicotine dependence and genetic variation in the nicotinic receptors. Drug Alcohol Dependence, 104 Suppl 1:S64-S69.
• Benowitz, N.L. (2008). Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics, 83, 531-541.
• Britton, J., Bogdanovica, I. (2013). Tobacco control eff orts in Europe. Lancet, 381, 1588- 1595.
• Brody, A.L., Mandelkern, M.A., London, E.D., Khan. A., Kozman, D., Costello, M.R., Vellios, E.E., Archie, M.M., Bascom, R., Mukhin, A.G. (2011). Eff ect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Archives of General Psychiatry, 68, 953–960.
• Brody, A.L., Mandelkern, M.A., London, E.D., Olmstead, R.E., Farahi, J., Scheibal, D., Jou, J., Allen, V., Tiongson, E., Chefer, S.I., Koren, A.O., Mukhin, A.G. (2006). Cigarette smoking saturates brain α4β2 nicotinic acetylcholine receptors. Archives of General Psychiatry, 63, 907–915.
• Brown, R.A., Lejuez, C.W., Kahler, C.W., Strong, D.R., Zvolensky, M.J. (2005). Distress tolerance and early smoking lapse. Clinical Pyschology Review, 25, 713-733.
• Carrasco, C., Vicens, P., Redolat, R. (2006). Neuroprotective eff ects of behavioural training and nicotine on age-related defi cits in spatial learning. Behavioural Pharmacology, 17, 441-452.
• Courtwrigh, D.T. (2002). Las drogas y la formación del mundo moderno: breve historia de las sustancias adictivas. Paidós Ibérica: Barcelona.
• De Biasi, M., Dani, J.A. (2011). Reward, addiction, withdrawal to nicotine. Annual Review of Neuroscience, 34, 105-130.
• Díez García, R. (2012). Creencias y actitudes de los jóvenes en relación al tabaco: valoración e impacto de la inclusión de imágenes en los paquetes de tabaco. Revista Española de Drogodependencias, 37, 23-26.
• Dovrack, R.D., Simons, J.S. (2008). Aff ective diff erences among daily tobacco users, occasional users, and non-users. Addictive Behaviors, 33, 211-216.
• D’Souza, M.S., Markou, A. (2011) Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addiction Science & Clinical Practice, 6, 4-16.
• D’Souza, M.S., Markou, A. (2012). Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology, 62, 1564-73.
• Dwyer, J.B., McQuown, S.C., Leslie, F.M. (2009). The dynamic eff ects of nicotine on the developing brain. Pharmacology & Therapeutics, 122, 125-139.
• European Commission (2012). Attitudes of europeans towards tobacco. Special Eurobarometer 385 http://ec.europa.eu/public_opinion/index_en.htm
• Fernández, E., Becoña, E. (2009). Trastornos de personalidad en fumadores: una revisión. Adicciones, 22, 155-172.
• Graef, S., Schönknecht, P., Sabri, O., Hegerl, U. (2011). Cholinergic receptor subtypes and their role in cognition, emotion and vigilance control: an overview of preclinical and clinical fi ndings. Psychopharmacology, 215, 205-229.
• Hatsukami, D., Fletcher, L., Morgan, S., Keenan, R., Amble, P. (1989). The eff ects of varying cigarette deprivation duration on cognitive and performance tasks. Journal of Substance Abuse, 1, 407-416.
• Heishman, S.J., Kleykamp, B.A., Singleton, E.G. (2010). Meta-analysis of the acute eff ects of nicotine and smoking on human performance. Psychopharmacology, 210, 453-469.
• Hogle, J.M., Curtin, J.J. (2006). Sex diff erences in negative aff ective response during nicotine withdrawal. Psychophysiology, 43, 344-356.
• Hughes, J.R. (2007). Measurement of the eff ects of abstinence from tobacco: A qualitative review. Psychology of Addictive Behaviors, 21, 127-137.
• Hughes, J.R., Higgins, S.T., Bickel, W.K. (1994). Nicotine withdrawall versus other drug withdrawall syndromes: similarities and dissimilarities. Addiction, 89, 1461-1470.
• Instituto Nacional de Estadística (2009). Clasifi cación Nacional de Actividades Económicas CNAE2009. Ministerio de Economía. Madrid.
• Kotnowski, K., Hammond, D. (2013). The impact of cigarette pack shape, size and opening: evidence from tobacco company documents. Addiction, (en prensa) doi:10.1111/ add.12183
• Kouvonen, A., Kivimäki, M., Virtanen, M., Pentti, J., Vahtera, J. (2005). Work stress, smoking status, and smoking intensity: an observational study of 46,190 employees. Journal of Epidemiology and Community Health, 59, 63-69.
• Levin, E.D., McClernon, F.J., Rezvamo, A.H. (2006). Nicotinic eff ects on cognitive function: behavioral characterization, pharmacological specifi cation, and anatomic localization. Psychopharmacology, 184, 523-539.
• Ley 28/2005 de 26 de diciembre, de medidas sanitarias frente al tabaquismo y reguladora de la venta, el suministro, el consumo y la publicidad de los productos del tabaco. Boletín Ofi cial del Estado 309 de 27 de diciembre de 2005; 42241-42250.
• Ley 42/2010, de 30 de diciembre, por la que se modifica la Ley 28/2005, de 26 de diciembre, de medidas sanitarias frente al tabaquismo y reguladora de la venta, el suministro, el consumo y la publicidad de los productos del tabaco. Boletín Oficial del Estado 218 de 30 de diciembre; 109188-109194.
• Lezak, M.D. (1995). Neuropsychological assessment. New York: Oxford.
• Mackay, J., Eriksen, M. (2002). The Tobacco Atlas. Organización Mundial de la Salud: Ginebra.
• Mackowick, K.M., Lynch, M.J., Weinberger, A.H., George, T.P. (2012). Treatment of tobacco dependence in people with mental health and addictive disorders. Current Psychiatry Reports, 14, 478-485.
• Markou, A. (2008). Neurobiology of nicotine dependence. Philosophical Transactions of the Royal Society B, 363, 3159-3168.
• McGranahan, T.M., Patzlaff , N.E., Grady, S.R., Heinemann, S.F., Booker, T.K. (2011). α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. Journal of Neuroscience, 31,10891-10902.
• Mineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G., Calarco, C. A., Li, A. M., Picciotto, M. R. (2013). Cholinergic signaling in the hi- ppocampus regulates social stress resilience, anxietyand depression-like behavior. Proceedings of the National Academy of Sciences USA, 110, 3573-3578.
• Moylan, S., Jacka, F.N., Pasco, J.A., Berk, M. (2013). How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain and Behavior, 3, 302-326.
• Mudo, G., Belluardo, N., Fuxe, K. (2007).
• Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms. Journal of Neural Transmission, 114, 135-147.
• Musso, F., Bettermann, F., Vucirevoc, G., Stoeter, P., Konrad, A., Winterer, G. (2007). Smoking impacts on prefrontal attentional network function in young adult brains. Psychopharmacology, 191, 159-69.
• Organización Mundial de la Salud (2003). Convenio Marco para el Control del Tabaco. Ginebra.
• Organización Mundial de la Salud (2011). Informe OMS sobre la epidemia mundial del tabaquismo. Ginebra.
• Organización Mundial de la Salud (2013). Tabaco. Nota descriptiva n.° 339. Mayo de 2013. Ginebra.
• Organización Mundial de la Salud (2013). 2012 Informe mundial sobre los progresos realizados en la aplicación del Convenio Marco de la OMS para el Control del Tabaco. Ginebra.
• Pagani, L.S. (2013). Environmental tobacco smoke exposure and brain development: The case of attention defi cit/hyperactivity disorder. Neuroscience and Biobehavioral Reviews, (en prensa) doi:pii: S0149-7634(13)00068-7. 10.1016/j.neubiorev.2013.03.008
• Paolini, M., De Biasi, M. (2011). Mechanistic insights into nicotine withdrawal. Biochemical Pharmacology, 82, 996–1007.
• Parrott, A.C., Murphy, R.S. (2012). Explaining the stress-inducing eff ects of nicotine to cigarette smokers. Human Psychopharmacology, 27,150-155.
• Pearl, R (1938). Tobacco smoking and longevity. Science, 87, 216–217.
• Perkins, K.A., Karelitz, J.L., Giedgowd, G.E., Conklin, C.A. (2013). Negative mood eff ects on craving to smoke in women versus men. Addictive Behaviors, 38, 1527-1531.
• Picciotto, M., Addy, N., Mineur, Y., Brunzell, D. (2008). It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Progress in Neurobiology, 84, 329-342.
• Picciotto, M.R., Mineur, Y.S. (2013). Molecules and circuits involved in nicotine addiction: the many faces of smoking. Neuropharmacology, (en prensa) doi:pii: S0028-3908(13)00174-3. 10.1016/j.neuropharm.2013.04.028
• Philip, N.S., Carpenter, L.L., Tyrka, A.R., Price, L.H. (2010). Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology, 212, 1-12.
• Pormerleau, O.F., Pormeleau, C.S., Mehringer, A.M., Snedecor, S., Ninowski, R., Sen, A. (2005). Nicotine dependence, depression, and gender: Characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nicotine Tobacco Research, 7, 91-102.
• Potter, A.S., Newhouse, P.A. (2008). Acute nicotine improves cognitive defi cits in young adults with attention-deficit/hyperactivity disorder. Pharmacology, Biochemistry, and Behavior, 88, 407-417.
• Richards, J.M., Stipelman, B.A., Bornovalova, M.A., Daughters, S.B., Sinha, R., Lejuez, C.W. (2011). Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work. Biological Psychology, 88, 1-12.
• Shytle, R.D., Silver, A.A., Sanberg, P.R. (1996). Nicotine, tobacco and addiction. Nature, 384, 18-19.
• Swan, G.E., Lessov-Schlaggar, C.N. (2007). The eff ects of tobacco smoke and nicotine on cognition and the brain. Neuropsychology Review, 17, 259-273.
• U.S. Public Health Service (1964). Smoking and health. Report of the advisory committee to the Surgeon General of the Public Health Service (PHS Publication No. 1103). U.S. Government Printing Offi ce, Washington DC.
• U.S. Department of Health and Human Services (1988). The health consequences of smoking: Nicotine addiction. A report of the Surgeron General U.S. Department of Health and Human Services, Public Health Services, Office on smoking and health. DHHS Publication No. (CDC) 88-8406.
• Vassoler, F.M., Byrnes, E.M., Pierce, R.C. (2013). The Impact of Exposure to Addictive Drugs on Future Generations: Physiological and Behavioral Eff ects. Neuropharmacology (en prensa) doi: pii: S0028-3908(13)00284-0. 10.1016/j.neuropharm.2013.06.016
• Wallace, T.L., Bertrand, D. (2013). Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex. Biochemical Pharmacology, 85, 1713-1720.
• Xu, J., Mendrek, A., Cohen, M.S., Monterosso, J., Simon, S., Jarvik, M., Olmstead, R., Brody, A.L., Ernst, M., London, E.D. (2007). Eff ect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop task. Neuropsychopharmacology, 32, 1421-1428.